Potentially Preventable Spending Among High-Cost Medicare Patients: Implications for Healthcare Delivery
Overview
Authors
Affiliations
Background: High-cost patients account for a disproportionate share of healthcare spending. The proportion and distribution of potentially preventable spending among subgroups of high-cost patients are largely unknown.
Objective: To examine the distribution of potentially preventable spending among high-cost Medicare patients overall and potentially preventable spending associated with each high-cost category.
Design: A cross-sectional study. We merged Medicare claims and social determinants of health data to group patients into high-cost categories and quantify potentially preventable spending.
Patients: A total of 556,053 Medicare fee-for-service and dual-eligible beneficiaries with at least one healthcare encounter in the New York metropolitan area in 2014.
Main Measures: High-cost patients were mapped into 10 non-mutually exclusive categories. The primary outcome was episodic spending associated with preventable ED visits, preventable hospitalizations, and unplanned 30-day readmissions.
Key Results: Overall, potentially preventable spending accounted for 10.4% of overall spending in 2014. Preventable spending accounted for 13.3% of total spending among high-cost patients and 4.9% among non-high-cost patients (P < 0.001). Among high-cost patients, 44.0% experienced at least one potentially preventable encounter compared with 11.4% of non-high-cost patients (P < 0.001), and high-cost patients accounted for 71.5% of total preventable spending. High-cost patients had on average $11,502 in potentially preventable spending-more than 20 times more than non-high-cost patients ($510). High-cost patients in the seriously ill, frail, or serious mental illness categories accounted for the highest proportion of potentially preventable spending overall, while end-stage renal disease, serious illness, and opioid use disorder were associated with the highest preventable spending per patient.
Conclusion: Potentially preventable spending was concentrated among high-cost patients who were seriously ill, frail, or had a serious mental illness. Interventions targeting these subgroups may be helpful for reducing preventable utilization.
Subgroups of High-Cost Patients and Their Preventable Inpatient Cost in Rural China.
Lu S, Zhang Y, Ye T, Kringos D Int J Health Policy Manag. 2024; 13:8151.
PMID: 39099523 PMC: 11608279. DOI: 10.34172/ijhpm.2024.8151.
A Global Equity Model (GEM) for the Advancement of Community Health and Health Equity.
Offodile 2nd A, Gibbons J, Murrell S, Kinzer D, Sharfstein J NAM Perspect. 2023; 2022.
PMID: 36713771 PMC: 9875856. DOI: 10.31478/202211b.
Characterizing Potentially Preventable Hospitalizations of High-Cost Patients in Rural China.
Lu S, Zhang Y, Zhang L, Klazinga N, Kringos D Front Public Health. 2022; 10:804734.
PMID: 35211444 PMC: 8861072. DOI: 10.3389/fpubh.2022.804734.
Zhang Y, Flory J, Bao Y J Gen Intern Med. 2022; 37(14):3645-3652.
PMID: 35018567 PMC: 9585123. DOI: 10.1007/s11606-021-07334-y.
High-Cost Users of Prescription Drugs: National Health Insurance Data from South Korea.
Park D, Lee H, Kim D J Gen Intern Med. 2021; 37(10):2390-2397.
PMID: 34704207 PMC: 9360271. DOI: 10.1007/s11606-021-07165-x.